You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastro-Entero-Pancreatic Neuroendocrine Tumour

Showing 1 - 25 of 6,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastro-entero Pancreatic Neuroendocrine Tumors Trial in Italy

Recruiting
  • Gastro-entero Pancreatic Neuroendocrine Tumors
    • Rozzano, Milan, Italy
    • +35 more
    Oct 27, 2022

    Gastro-entero-pancreatic Neuroendocrine Tumors Trial in Meldola (Capecitabine, Lu-PRRT, SS-LAR)

    Active, not recruiting
    • Gastro-entero-pancreatic Neuroendocrine Tumors
    • Meldola, FC, Italy
      Irst Irccs
    Feb 25, 2021

    Neuroendocrine Tumors Trial in Meldola (177Lu-DOTATATE 25.9 GBq activity, 177Lu-DOTATATE 18.5 GBq activity)

    Active, not recruiting
    • Neuroendocrine Tumors
    • 177Lu-DOTATATE 25.9 GBq activity
    • 177Lu-DOTATATE 18.5 GBq activity
    • Meldola, FC, Italy
      Irst Irccs
    Feb 25, 2021

    Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors Trial in Meldola, Milan (28 GBq 177Lu-DOTATATE, 22 GBq

    Active, not recruiting
    • Neuroendocrine Tumors
    • Gastro Entero Pancreatic Neuroendocrine Tumors
    • 28 GBq 177Lu-DOTATATE
    • 22 GBq 177Lu-DOTATATE
    • Meldola, FC, Italy
    • +1 more
    Feb 25, 2021

    Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

    Withdrawn
    • Gastro-enteropancreatic Neuroendocrine Tumor
    • (no location specified)
    Feb 17, 2022

    Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

    Terminated
    • Gastrointestinal Cancer
    • +8 more
    • Serious Illness Conversation Guide (SICG)
    • Quality of Life (QOL) survey
    • Stanford, California
      Stanford Cancer Center
    Jan 25, 2023

    Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

    Terminated
    Has Results
    • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
    • Bruxelles, Belgium
    • +23 more
    Dec 21, 2022

    Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

    Recruiting
    • Neuroendocrine Carcinoma
    • FOLFOXIRI Protocol
    • Cisplatin injection
    • Caen, France
    • +5 more
    Apr 13, 2021

    Gastro-Enteropancreatic Neuroendocrine Tumor Trial in Austria, Denmark, United States (Satoreotide trizoxetan 5-20µg,

    Completed
    Has Results
    • Gastro-Enteropancreatic Neuroendocrine Tumor
    • Satoreotide trizoxetan 5-20μg
    • Satoreotide trizoxetan 30-45μg
    • Los Angeles, California
    • +4 more
    Jan 8, 2021

    Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor, Gastro-enteropancreatic Neuroendocrine Tumor Trial in Taiwan (CVM-1118)

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Kaohsiung, Taiwan
    • +6 more
    Aug 24, 2021

    Sunitinib In Chinese Progressive Advanced Or Metastatic

    Active, not recruiting
    • Pancreatic Neuroendocrine Tumors
    • Hefei, Anhui, China
    • +15 more
    Oct 19, 2021

    Viewpoints on Social Representations and Rationale Concerning

    Terminated
    • Non-resectable Metastatic Cancer of the Lung
    • +7 more
    • Interviews
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourogne
    Apr 14, 2022

    Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

    Recruiting
    • Neuroendocrine Carcinomas
    • Amiens, France
    • +26 more
    Jan 26, 2022

    Spanish Series of Patients Treated With Radionuclide Lutetium177

    Recruiting
    • Neuroendocrine Tumors
    • +17 more
    • Lutetium [177Lu] oxodotreotide/dotatate
    • Santiago De Compostela, A Coruña, Spain
    • +18 more
    Jul 1, 2021

    Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

    Recruiting
    • Neuroendocrine Tumor
    • +2 more
    • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
    • +3 more
    • Bordeaux, France
    • +3 more
    Nov 18, 2021

    Neuroendocrine Tumors Trial in Warszawa (177Lu-DOTATOC)

    Unknown status
    • Neuroendocrine Tumors
    • Warszawa, Poland
      Centrum Diagnostyczno-Lecznicze Gammed
    Nov 2, 2020

    Early Treatment Response in NEN (REBORN)

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Somatostatin analog; chemotherapy
    • Rome, Italy
      Andrea M Isidori
    Dec 2, 2020

    Effectiveness and Outcomes Associated With Lutathera Treatment

    Active, not recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Alessandria, Italy
    • +17 more
    May 4, 2022

    Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)

    Completed
    • Neuroendocrine Carcinoma
    • Los Angeles, California
      University of California Los Angeles, Nuclear Medicine Clinic of
    May 12, 2021

    Lung Neuroendocrine Tumor, GEP Neuroendocrine Tumor Trial in Naples (Cabozantinib and Temozolomide)

    Recruiting
    • Lung Neuroendocrine Neoplasm
    • GEP Neuroendocrine Tumor
    • Cabozantinib and Temozolomide
    • Naples, Campania, Italy
      National Cancer Institute of Naples
    Oct 12, 2021

    Neuroendocrine Tumors Trial in Milano (Y90-DOTA-Tyr3-Octreotide)

    Completed
    • Neuroendocrine Tumors
    • Milano, Italy
      Chiara Maria Grana
    Mar 3, 2020

    Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

    Recruiting
    • Neuroendocrine Tumor of Pancreas
    • Multiple Endocrine Neoplasia Type 1
    • High-dose-high precision MR-guided radiotherapy
    • Utrecht, Netherlands
      UMC Utrecht
    May 29, 2022

    Pancreatic Neuroendocrine Tumour Metastatic Trial in Spain (Sunitinib)

    Completed
    • Pancreatic Neuroendocrine Tumour Metastatic
    • Oviedo, Asturias, Spain
    • +8 more
    Mar 3, 2020

    Gastroenteropancreatic Neuroendocrine Tumors Trial in Basel (satoreotide trizoxetan)

    Completed
    Has Results
    • Gastroenteropancreatic Neuroendocrine Tumors
    • satoreotide trizoxetan
    • Basel, Switzerland
      University Hospital Basel
    Sep 5, 2019

    Cancer Death Using Less Invasive Diagnostic Tests- Liquid

    Unknown status
    • Neoplasm, Colorectal
    • +5 more
    • ctDNA blood sampling
    • Sutton, Surrey, United Kingdom
      Royal Marsden Hospital
    Sep 25, 2020